Joby Aviation, Inc. filed a prospectus supplement with the U.S. Securities and Exchange Commission on September 10, 2026. The filing relates to the resale of 2,419,801 shares of common stock held by a selling stockholder. These shares were issued by Joby to the stockholder in connection with the achievement of specific EBITDA milestones by acquired operations following the closing of the acquisition.
The acquisition referenced in the filing includes the passenger segment and operations of Strata Critical Medical, Inc. (formerly known as Blade Air Mobility, Inc.), Trinity Medical Intermediate II, Inc., and Blade Urban Air Mobility, Inc. The prospectus supplement is part of a larger Registration Statement on Form S-3 (No. 333-282809), which was originally filed with the Commission on October 24, 2024.
Attached to the filing is a legal opinion from Latham & Watkins LLP regarding the validity of the issuance of the common stock shares. The opinion is filed as Exhibit 5.1 to this Current Report on Form 8-K and is incorporated by reference into the Registration Statement.
